InhibOx is a computational drug discovery company
The company's primary objectives are:
To develop novel and effective computational methods for drug discovery in order to overcome
the acute problems of the lead identification and optimisation stages of drug development that the industry currently faces.
Combining these methods with it's excellent in-house drug discovery experience, to advance proprietary and collaborative
drug discovery programmes in order to generate value.
For collaborators, the advantages of working with InhibOx include lower costs and shorter timelines
to hits and access to our considerable drug discovery expertise. A further advantage is our close proximity to,
and links with, Oxford University Chemistry and Computer Science Departments. There is also the potential to
access high quality and very cost-effective synthetic chemistry via our broader collaborative network.
|
